Pricing Log in Create free account

SeaStar Medical Holding Corporation (ICU) vs Tempest Therapeutics, Inc. (TPST)

SeaStar Medical Holding Corporation and Tempest Therapeutics, Inc. are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $7.5M — 1.4× the size. SeaStar Medical Holding Corporation grew revenue faster over the last twelve months: 123.6% against −53.0%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, SeaStar Medical Holding Corporation leads on 10 and Tempest Therapeutics, Inc. on 4.

Valuation

Metric ICU TPST Biotechnology median
P/E n/m n/m 10.26
P/S 4.53 17.86 9.18
P/B 1.81 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.96 22.37 8.98
Earnings yield (205.79%) (1,178.26%) (34.89%)
Free cash flow yield (176.47%) (365.85%) (24.52%)

Profitability

Metric ICU TPST Biotechnology median
Gross margin 92.64% 0.00% 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (931.14%) (50.12%)
Return on assets (160.02%) (237.25%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ICU TPST Biotechnology median
Revenue growth (TTM) 123.63% (52.98%) 6.26%
EPS growth (last fiscal year) 91.16% 67.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 0.38 4.89
Net debt to EBITDA 0.99 0.29 1.01

Dividend

Metric ICU TPST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ICU TPST Biotechnology median
Market cap 10.20m 7.50m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack